FGF2 and cancer: Indeed, a clear correlation between API5 and FGF-2 expression was observed in an array of cancer cells, and forced expression or siRNA-mediated inhibition of API5 resulted in concomitant FGF-2 expression increase or decrease, respectively [31,33,80].